Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma

Journal of Cancer - Australia
doi 10.7150/jca.21747
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

PI3Kδ Is a New Therapeutic Target in Hepatocellular Carcinoma

Hepatology
MedicineHepatology
2018English

C-Met: A Potential Therapeutic Target for Hepatocellular Carcinoma

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2011English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

CCN3 Is a Therapeutic Target Relating Enhanced Stemness and Coagulation in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2017English

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

SLAMF7 (CD319/CS1) Is Expressed in Plasmablastic Lymphoma and Is a Potential Diagnostic Marker and Therapeutic Target

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy